Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study

被引:11
|
作者
Wan, Kim Sui [1 ,2 ]
Moy, Foong Ming [1 ]
Mohd Yusof, Khalijah [2 ,4 ]
Mustapha, Feisul Idzwan [3 ]
Mohd Ali, Zainudin [2 ]
Hairi, Noran Naqiah [1 ]
机构
[1] Univ Malaya, Fac Med, Ctr Epidemiol & Evidence Based Practice, Dept Social & Prevent Med, Kuala Lumpur, Malaysia
[2] State Hlth Dept Negeri Sembilan, Seremban, Malaysia
[3] Minist Hlth, Dis Control Div, Putrajaya, Malaysia
[4] State Hlth Dept Johor, Johor Baharu, Malaysia
来源
PLOS ONE | 2020年 / 15卷 / 10期
关键词
TREATMENT INTENSIFICATION; THERAPY; PEOPLE; HYPERGLYCEMIA; ADHERENCE;
D O I
10.1371/journal.pone.0240531
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Clinical inertia can lead to poor glycemic control among type 2 diabetes patients. However, there is paucity of information on clinical inertia in low- and middle-income countries including Malaysia. This study aimed to determine the time to treatment intensification among T2D patients with HbA1c of >= 7% (>= 53 mmol/mol) in Malaysian public health clinics. The proportion of patients with treatment intensification and its associated factors were also determined. Material and methods This was a five-year retrospective open cohort study using secondary data from the National Diabetes Registry. The study setting was all public health clinics (n = 47) in the state of Negeri Sembilan, Malaysia. Time to treatment intensification was defined as the number of years from the index year until the addition of another oral antidiabetic drug or initiation of insulin. Life table survival analysis based on best-worst case scenarios was used to determine the time to treatment intensification. Discrete-time proportional hazards model was fitted for the factors associated with treatment intensification. Results The mean follow-up duration was 2.6 (SD 1.1) years. Of 7,646 patients, the median time to treatment intensification was 1.29 years (15.5 months), 1.58 years (19.0 months) and 2.32 years (27.8 months) under the best-, average- and worst-case scenarios respectively. The proportion of patients with treatment intensification was 45.4% (95% CI: 44.2-46.5), of which 34.6% occurred only after one year. Younger adults, overweight, obesity, use of antiplatelet medications and poorer HbA1c were positively associated with treatment intensification. Patients treated with more oral antidiabetics were less likely to have treatment intensification. Conclusion Clinical inertia is present in the management of T2D patients in Malaysian public health clinics. We recommend further studies in lower- and middle-income countries to explore its causes so that targeted strategies can be developed to address this issue.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Childhood intussusception: a multicentre study in a middle-income country
    Ajao, A. E.
    Kumolalo, F. O.
    Olulana, D., I
    Gundoyin, O. O.
    Lawal, T. A.
    SOUTH AFRICAN JOURNAL OF SURGERY, 2020, 58 (03) : 138 - 142
  • [22] Clinical Inertia in People With Type 2 Diabetes A retrospective cohort study of more than 80,000 people
    Khunti, Kamlesh
    Wolden, Michael L.
    Thorsted, Brian Larsen
    Andersen, Marc
    Davies, Melanie J.
    DIABETES CARE, 2013, 36 (11) : 3411 - 3417
  • [23] Digital Clinical Placements": Challenges in a Lower Middle-Income Country
    Guragai, Mandeep
    ACADEMIC MEDICINE, 2021, 96 (01) : E1 - E1
  • [24] Evaluation of outpatient health services in diabetes mellitus in a middle-income setting: a retrospective cohort study involving secondary care
    de Oliveira, Felipe Martins
    Chiaradia, Caio
    Zaia, Silvana Marques
    Ordonha, Ana Carolina Xavier
    Garcia, Sonia Aparecida Dias
    Reis, Ligia Dinara Donizeti
    Ribeiro, Manoel Carlos Sampaio de Almeida
    Salles, Joao Eduardo Nunes
    ACTA SCIENTIARUM-HEALTH SCIENCES, 2023, 45
  • [25] Performance of the Dutch clinical prediction rule for the ambulation outcome after spinal cord injury in a middle-income country clinical setting: an external validation study in the Thai retrospective cohort
    Rajchagool, Buddharaksa
    Wongyikul, Pakpoom
    Lumkul, Lalita
    Phinyo, Phichayut
    Pattanakuhar, Sintip
    SPINAL CORD, 2023, 61 (11) : 608 - 614
  • [26] Performance of the Dutch clinical prediction rule for the ambulation outcome after spinal cord injury in a middle-income country clinical setting: an external validation study in the Thai retrospective cohort
    Buddharaksa Rajchagool
    Pakpoom Wongyikul
    Lalita Lumkul
    Phichayut Phinyo
    Sintip Pattanakuhar
    Spinal Cord, 2023, 61 : 608 - 614
  • [27] Feasibility of prevention of type 2 diabetes in low- and middle-income countries
    Andre P. Kengne
    Ambady Ramachandran
    Diabetologia, 2024, 67 : 763 - 772
  • [28] Neonatal Surgical Morbidity and Mortality at a Single Tertiary Center in a Low- and Middle-Income Country: A Retrospective Study of Clinical Outcomes
    Hasan, Md Samiul
    Islam, Nazmul
    Mitul, Ashrarur Rahman
    FRONTIERS IN SURGERY, 2022, 9
  • [29] Feasibility of prevention of type 2 diabetes in low- and middle-income countries
    Kengne, Andre P.
    Ramachandran, Ambady
    DIABETOLOGIA, 2024, 67 (05) : 763 - 772
  • [30] PREVIOUS MANAGEMENT OF MEDULLOBLASTOMA IN A MIDDLE-INCOME COUNTRY: IDENTIFYING AREAS FOR IMPROVEMENT
    Sanchez, Mauricio
    Gamboa, Yessika
    Delgado, Mario
    Garita, Karla
    Esquivel, Jessica
    Rodriguez, Carlos
    Caceres, Adrian
    Leis, Amanda
    Acuna, Maria Jose
    Nunez, Monica
    NEURO-ONCOLOGY, 2024, 26